Silver Book Fact

Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually

Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.

Rboerts R, Hota B, Ahmad I, Scott R, et al. Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship. Clin Infect Dis. 2009; 49(8): 1175-84. http://cid.oxfordjournals.org/content/49/8/1175.full

Reference

Title
Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship
Publication
Clin Infect Dis
Publication Date
2009
Authors
Rboerts R, Hota B, Ahmad I, Scott R, et al.
Volume & Issue
Volume 49, Issue 8
Pages
1175-84
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • ~70% of hospital HAIs resistant to ≥ antimicrobial
    Approximately 70% of hospital-acquired HAIs are resistant to at least one antimicrobial drug.  
  • HAI Annual Cost
    Healthcare-associated infections in US hospitals cost $96–$147 billion annually.  
  • MRSA infections increase in older patients
    In 2008, 75% of healthcare-associated invasive MRSA infections occurred in patients older than 50, with 46% in patients older than 65%.  
  • Close to 1/2 of HAIs in patients 65+
    Around 45% of all hospital-acquired HAIs in 2007 were in patients age 65 and older.  
  • Enormous annual direct cost of HAIs to hospitals
    The annual direct cost of healthcare-associated infections to U.S. hospitals ranges from $28.4 billion to $45 billion.